ACADIA PHARMACEUTICALS INC ACAD
ACADIA PHARMACEUTICALS INC statistics & valuation
Market cap$4.3B
P / E11.1×
P / S4.0×
P / B3.5×
P / FCF41.2×
Net margin36.5%
Return on equity31.9%
FCF margin9.8%
Return on capital8.1%
Graham number -34.4%$19.31
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value ($19.31); a green figure means the price is below it.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | — | — | 94.3% | 98.0% | 97.8% | 97.7% | 96.7% | 94.5% | 92.7% | 82.2% |
| Operating margin | 9.8% | 24.1% | -10.1% | -43.2% | -35.2% | -64.9% | -72.7% | -110.6% | -234.1% | -1574.1% |
| Net margin | 36.5% | 23.6% | -8.4% | -41.8% | -34.7% | -63.7% | -69.4% | -109.6% | -231.7% | -1565.9% |
| FCF margin | 9.8% | 16.4% | 2.3% | -22.0% | -26.2% | -32.5% | -44.9% | -75.8% | -175.1% | -1222.7% |
| Return on assets | 25.0% | 19.1% | -8.2% | -36.7% | -24.0% | -36.0% | -30.0% | -45.4% | -75.3% | -48.4% |
| Return on equity | 31.9% | 30.9% | -14.2% | -53.9% | -31.0% | -44.9% | -33.7% | -51.2% | -86.3% | -52.4% |
| Current ratio | 3.83 | 2.38 | 2.42 | 4.04 | 6.43 | 6.77 | 10.16 | 8.83 | 7.62 | 12.87 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.